Cover Image

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants

Multivalent combination vaccines have reduced the number of injections and therefore improved vaccine acceptance, timeliness of administration and global coverage. The hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus/Haemophilus influenzae type b (DTPa-HBV-IPV/Hib...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sanjay K. Lalwani (Author), Sharad Agarkhedkar (Author), Balasubramanian Sundaram (Author), Niranjana S. Mahantashetti (Author), Nandini Malshe (Author), Shalaka Agarkhedkar (Author), Olivier Van Der Meeren (Author), Shailesh Mehta (Author), Naveen Karkada (Author), Htay Htay Han (Author), Narcisa Mesaros (Author)
Format:	Book
Published:	Taylor & Francis Group, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants
by: Yanping Li, et al.
Published: (2017)

Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy
by: Tino F. Schwarz, et al.
Published: (2019)

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine
by: Julianne Bayliss, et al.
Published: (2021)

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa
by: Timo Vesikari, et al.
Published: (2017)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
by: Ki Hwan Kim, et al.
Published: (2019)

A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
by: Andrea Guerra, et al.
Published: (2024)

Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries
by: Marina George, et al.
Published: (2023)

Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China
by: Aodi Huang, et al.
Published: (2024)

Rejoinder to comments on ''Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China''
by: Floriano Amimo
Published: (2024)

Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis
by: Htay Htay Han, et al.
Published: (2017)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study
by: Victor Romanenko, et al.
Published: (2020)

Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models
by: Yuntao Zhang, et al.
Published: (2022)

DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers
by: Andrew W. Lee, et al.
Published: (2017)

DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure
by: Florence Boisnard, et al.
Published: (2023)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
by: Marissa B. Wilck, et al.
Published: (2021)

Comparison of Local and Systemic DTPA Treatment Efficacy According to Actinide Physicochemical Properties Following Lung or Wound Contamination in the Rat
by: Nina M. Griffiths, et al.
Published: (2021)

Adverse events following immunization of co- and separate administration of DTaP-IPV/Hib vaccines: A real-world comparative study
by: Yiqing Zhu, et al.
Published: (2024)

Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study
by: Thomas Aamand, et al.
Published: (2023)

A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16-24 months
by: Hitt Sharma, et al.
Published: (2022)

Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India
by: Sharad Agarkhedkar, et al.
Published: (2019)

Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously
by: Anitta Ahonen, et al.
Published: (2022)

Prevalence and perceptions of infant massage in India: study from Maharashtra and Madhya Pradesh states
by: Sarika Chaturvedi, et al.
Published: (2020)

Design and testing of an experimental IPv4-to-IPv6 transition network / Mustaffa Samad
by: Samad, Mustaffa
Published: (2006)

Ibrutinib-induced cardiomyopathy
by: Htay Htay Kyi, et al.
Published: (2019)

Implementasi Interkoneksi IPV6 Dan IPV4 Menggunakan Clearos Enterprise 5.1
by: Aghi, Risada, et al.
Published: (2013)

IPV Screening and Readiness to Respond to IPV in Ob-Gyn Settings: A Patient-Physician Study
by: Katherine M. Jones, et al.
Published: (2018)

Performance comparison of multimedia application over IPv4 and IPv6 network / Ummi Suraya Shaharuddin
by: Shaharuddin, Ummi Suraya
Published: (2016)

Rapid assessment of Hib disease burden in Vietnam
by: Slack Mary PE, et al.
Published: (2011)

Global Hib vaccination: reasons to cheer and fear
by: Stephen R C Howie
Published: (2016)

The immunogenicity and safety of the new, Indonesian DTwP-HB-Hib vaccine compared to the DTwP/HB vaccine given with the Hib vaccine
by: Novilia Sjafri Bachtiar, et al.
Published: (2017)

Hib vaccine: Should it be introduced in the national immunization program?
by: Davendra K Taneja
Published: (2012)

HIB-INFECTION: MENINGITIS, CELLULITIS IN THE CHILD OF 6 MONTHS
by: G. A. Harchenko, et al.
Published: (2015)

Ion-pairing HPLC methods to determine EDTA and DTPA in small molecule and biological pharmaceutical formulations
by: George Wang, et al.
Published: (2016)

The effectiveness of the role of advanced nurse practitioners compared to physician-led or usual care: A systematic review
by: Maung Htay, et al.
Published: (2021)

The progress of postapproval clinical studies on Sabin IPV
by: Li Shi, et al.
Published: (2022)

A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants
by: Diego Mpia Elenge, et al.
Published: (2024)

The quantity and quality of anti-PRP induced by the new Indonesian DTwP-HB-Hib vaccine compared to the Hib vaccine given with the DTwP-HB vaccine
by: Novilia Sjafri Bachtiar, et al.
Published: (2018)

Synthesis and characterization of a novel chemically designed (Globo)3–DTPA–KLH antigen
by: Hajmohammadi M, et al.
Published: (2014)

DTPA-Bound Planar Catechin with Potent Antioxidant Activity Triggered by Fe<sup>3+</sup> Coordination
by: Kiyoshi Fukuhara, et al.
Published: (2023)